Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus

The results of the present study suggest that ASA score ≤ 2 and use of rifampin-combination therapy are two independent factors associated with favorable outcome of patients treated for total hip or knee prosthetic infections due to S. aureus.

[1]  C. Salgado,et al.  Higher Risk of Failure of Methicillin-resistant Staphylococcus aureus Prosthetic Joint Infections , 2007, Clinical orthopaedics and related research.

[2]  W. Zimmerli,et al.  Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  E. Moran,et al.  Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. , 2007, The Journal of infection.

[4]  C. Sledge,et al.  Factors Influencing the Incidence and Outcome of Infection Following Total Joint Arthroplasty , 1984, Clinical orthopaedics and related research.

[5]  S. Kurtz,et al.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. , 2007, The Journal of bone and joint surgery. American volume.

[6]  A. Widmer,et al.  Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Hanssen,et al.  Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  L. Aguilar,et al.  Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. , 2006, The American journal of medicine.

[9]  P E Ochsner,et al.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.

[10]  P. Gulbrandsen,et al.  Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  D. Neogi,et al.  Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin‐based regimen , 2008, Acta orthopaedica.

[12]  W. Zimmerli,et al.  Management of Infection Associated with Total Hip Arthroplasty according to a Treatment Algorithm , 2004, Infection.

[13]  P. Choong,et al.  Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  D. Raoult,et al.  Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants , 1993, Antimicrobial Agents and Chemotherapy.

[15]  B. Morrey,et al.  Treatment of infection after total knee arthroplasty by débridement with retention of the components. , 1990, The Journal of bone and joint surgery. American volume.

[16]  D. Raoult,et al.  Ambulatory Treatment of Multidrug-ResistantStaphylococcus-Infected Orthopedic Implants with High-Dose Oral Co-trimoxazole (Trimethoprim-Sulfamethoxazole) , 1998, Antimicrobial Agents and Chemotherapy.

[17]  K. Calligaro.  Infections associated with indwelling medical devices , 1995 .

[18]  B. Richard.  Interosseous transfer of tibialis posterior for common peroneal nerve palsy. , 1989, The Journal of bone and joint surgery. British volume.

[19]  H. Amstutz,et al.  Direct-Exchange Arthroplasty for the Treatment of Infection after Total Hip Replacement. An Average Ten-Year Follow-up* , 1998, The Journal of bone and joint surgery. American volume.

[20]  D. Biau,et al.  Outcome of group B streptococcal prosthetic hip infections compared to that of other bacterial infections. , 2009, Joint, bone, spine : revue du rhumatisme.

[21]  Á. Soriano,et al.  Treatment of acute post-surgical infection of joint arthroplasty. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  N. Athanasou,et al.  Histological and microbiological findings in non-infected and infected revision arthroplasty tissues , 2000, Archives of Orthopaedic and Trauma Surgery.

[23]  R. Trebše,et al.  Treatment of infected retained implants. , 2005, The Journal of bone and joint surgery. British volume.

[24]  R. Gustilo,et al.  Infection after Total Hip Arthroplasty. A Study of the Treatment of One Hundred and Six Infections* , 1996, The Journal of bone and joint surgery. American volume.

[25]  T. Sculco.  The economic impact of infected joint arthroplasty. , 1995, Orthopedics.

[26]  C. Girard-Longhini,et al.  [Postoperative infection]. , 1972, Cahiers d'anesthesiologie.

[27]  I. Sia,et al.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[28]  D. Fisman,et al.  Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  D. Ilstrup,et al.  Revision total hip arthroplasty. , 1985, The Journal of bone and joint surgery. American volume.

[30]  Á. Soriano,et al.  Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  M. Dudley,et al.  Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. , 1991, The American journal of medicine.

[32]  A. Widmer,et al.  Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. , 1994, The Journal of antimicrobial chemotherapy.

[33]  B. Morrey,et al.  Treatment of Infection with Débridement and Retention of the Components following Hip Arthroplasty* , 1998, The Journal of bone and joint surgery. American volume.

[34]  D. Ilstrup,et al.  Two-stage reconstruction of a total hip arthroplasty because of infection. , 1989, The Journal of bone and joint surgery. American volume.

[35]  D. Raoult,et al.  Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. , 1997, The Journal of antimicrobial chemotherapy.

[36]  M. Herrmann,et al.  Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations , 1991, Antimicrobial Agents and Chemotherapy.

[37]  F. Waldvogel,et al.  Infections Associated With Indwelling Medical Devices , 1989 .

[38]  P. François,et al.  Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection , 2010, European Journal of Clinical Microbiology & Infectious Diseases.